Aspira Pathlab & Diagnostics L

BSE: 540788 29 Jun 2025

Healthcare

₹ 56.8

Aspira Pathlab & Diagnostics Limited specializes in Healthcare Service Provider within the Healthcare sector.

Aspira Pathlab & Diagnostics L

BSE: 540788 29 Jun 2025

Healthcare

₹ 56.8

Aspira Pathlab & Diagnostics Limited specializes in Healthcare Service Provider within the Healthcare sector.

Book Value

11.9

Dividend Yield

0.0%

Debt to Equity

0.26

Stock P/E

28.3

Market Cap

58.7 Cr

Aspira Pathlab & Diagnostics L - Share Price & Details

Market Cap

₹58.7

High /Low

107.0 / 27.0

Stock P/E

28.3

Book Value

₹11.9

Dividend Yield

0.0

ROCE

17.2

ROE

₹23.8

Face Value

10.0

PEG Ratio

1.42

EVEBITDA

₹15.2

Debt

3.20

CMP / FCF

75.0

Debt to equity

₹0.26

NP Ann

2.07

High price all time

124.0

Piotroski score

₹8.0

Graham Number

23.2

No. Eq. Shares

1.03

Net CF

₹0.95

Net profit

2.07

Price to book value

4.81

Interest Coverage

₹6.94

Low price all time

14.2

Industry PE

47.5

Reserves

₹1.92

Free Cash Flow

₹1.71

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
LOOKS HEALTH SERVICES LIMITED	NA	NA	NA	NA	5.11	256.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
Aspira Pathlab & Diagnostics L	NA	NA	NA	NA	58.7	28.3
DIPNA PHARMACHEM LIMITED	NA	NA	NA	NA	55.5	66.9
MEDI-CAPS LTD.	NA	NA	NA	NA	53.6	95.8

Peer Comparison Chart

About Aspira Pathlab & Diagnostics L

Aspira Pathlab & Diagnostics Limited, with Security Code 540788, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

KJMC Corporate Advisors (India) reports consolidated net loss of Rs 0.43 crore in the March 2025 quarter

(20 May 2025)

Sales decline 52.59% to Rs 1.19 crore.

Aspira Pathlab Standalone March 2025 Net Sales at Rs 5.78 crore, up 51.31% Y-o-Y

(19 May 2025)

Net Sales at Rs 5.78 crore in March 2025 up 51.31% from Rs. 3.82 crore in March 2024. Story continues below Advertisement.

Aspira Pathlab & Diagnostics reports consolidated net profit of Rs 0.68 crore in the March 2025 quarter

(17 May 2025)

Sales rise 51.31% to Rs 5.78 crore. Net profit of Aspira Pathlab & Diagnostics reported to Rs 0.68 crore in the quarter ended March 2025 as...

Quarterly Table

Standalone Consolidated

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	3.7	4.4	3.4	2.6	3.3	3.5	3.8	4.6	6.2	5.4
Expenses	3.3	3.6	3.3	2.9	3.7	3.8	3.9	4.3	4.8	4.6
Operating Profit	0.5	0.8	0.1	-0.3	-0.4	-0.4	-0.1	0.3	1.4	0.8
OPM %	12.32%	18.7%	4.17%	-12.52%	-11.08%	-10.75%	-3.09%	7.53%	21.98%	14.2%
Other Income	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Interest	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Depreciation	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4
Profit before tax	0.0	0.4	-0.3	-0.7	-0.7	-0.7	-0.5	0.0	1.0	0.4
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	0.0	0.4	-0.3	-0.7	-0.7	-0.7	-0.5	0.0	1.0	0.4
EPS in Rs	0.01	0.43	-0.25	-0.7	-0.69	-0.72	-0.49	-0.02	0.96	0.37

Metrics	Jun 2024	Jun 2024	Sep 2024	Dec 2024
Sales	4.6	4.6	6.2	5.4
Expenses	4.3	4.3	4.8	4.6
Operating Profit	0.3	0.3	1.4	0.8
OPM %	7.53%	7.53%	21.98%	14.2%
Other Income	0.1	0.1	0.1	0.0
Interest	0.1	0.1	0.1	0.1
Depreciation	0.4	0.4	0.4	0.4
Profit before tax	0.0	0.0	1.0	0.4
Tax %	0%	0%	0%	0%
Net Profit	0.0	0.0	1.0	0.3
EPS in Rs	0.1	0.1	0.96	0.3

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	21%
3 Years:	4%
TTM:	67%

Compounded Profit Growth
10 Years:	59%
5 Years:	20%
3 Years:	-23%
TTM:	178%

Stock Price CAGR
10 Years:	0%
5 Years:	9%
3 Years:	3%
1 Year:	89%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	67%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	176%

Stock Price CAGR
10 Years:	0%
5 Years:	9%
3 Years:	3%
1 Year:	89%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Aspira Pathlab & Diagnostics L

Aspira Pathlab & Diagnostics L

Aspira Pathlab & Diagnostics L - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Aspira Pathlab & Diagnostics L

Latest News

Who are in the management team of Aspira Pathlab?

Aspira Pathlab & Diagnostics schedules board meeting

Aspira Pathlab Experiences Notable Buying Surge Amid Broader Market Decline

KJMC Corporate Advisors (India) reports consolidated net loss of Rs 0.43 crore in the March 2025 quarter

Aspira Pathlab Standalone March 2025 Net Sales at Rs 5.78 crore, up 51.31% Y-o-Y

Aspira Pathlab & Diagnostics reports consolidated net profit of Rs 0.68 crore in the March 2025 quarter

Aspira Pathlab Reports Strong Profit Growth and Revenue Surge in March 2025 Results

We Win consolidated net profit rises 17.39% in the March 2025 quarter

Western Carriers (India) consolidated net profit declines 41.82% in the March 2025 quarter

NESCO consolidated net profit declines 15.71% in the March 2025 quarter

JK Agri Genetics reports standalone net loss of Rs 1.35 crore in the March 2025 quarter

Q4 results on May 16: Hyundai Motor, BHEL, Emami, GIC Housing and others to declare earnings; check list

Q4 Results 2025 Today: BHEL, Hyundai Motor India, Shipping Corporation Among 100+ Firms To Declare Earnings

ASPIRA PATHLAB AND DIAGNOSTICS TO DECLARE QUARTERLY RESULTS

Sensex rises! These stocks are up over 15% on BSE

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

Diagnostic stocks surge amid HMPV scare

CAG report reveals majority of blood banks in Bihar operate without licenses

Aspira Pathlab & Diagnostics Reaches New 52-Week High, Outperforms Sector and Sensex

Suraksha Diagnostic IPO received 11% subscription on first day

Aspira Pathlab & Diagnostics Surges to 52-Week High, Outperforms Sensex in Healthcare Industry

Aspira Pathlab & Diagnostics Hits 52-Week High, Outperforms Sector by 0.34%

Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

Aspira Pathlab & Diagnostics' Stock Surges to 52-Week High, Outperforming Sector

NMDC Steel reports standalone net loss of Rs 595.37 crore in the September 2024 quarter

Q2 Results Today: Nykaa, Hyundai Motor India, Sula Vineyards among 554 companies to post earnings on November 12

Q2 Results Today: Nykaa, Hyundai Motor India, Sula Vineyards among 554 companies to post earnings on November 12 | Company Business News

Q2 Results Today: Nykaa, Hyundai Motor India, Sula Vineyards सहित 554 कंपनियों के नतीजे आज

Aspira Pathlab & Diagnostics Surges to 52-Week High, But Stock Call Remains 'Sell' According to MarketsMOJO

Aspira Pathlab & Diagnostics reports standalone net profit of Rs 0.99 crore in the September 2024 quarter

Aspira Pathlab Standalone September 2024 Net Sales at Rs 6.18 crore, up 85.99% Y-o-Y

Havells looks to triple revenue to Rs20,000 crore in 5 years | Company Business News

Hyundai Motor India, P N Gadgil Jewellers Among 500+ Companies To Declare Q2 Results Today

Borosil Scientific standalone net profit declines 0.65% in the September 2024 quarter

Aspira Pathlab & Diagnostics' Stock Reaches 52-Week High, But Rated as 'Sell' by MarketsMOJO

Aspira Pathlab & Diagnostics' Stock Reaches 52-Week High, Outperforms Sensex in Past Year

Over 500 firms to post their Q2FY25 results; Hyundai Motor, Zydus Lifesciences, PNG Gadgil Jewellers &...

Aspira Pathlab & Diagnostics' Stock Surges, Outperforms Sector by 3.82% in 2 Days

Aspira Pathlab & Diagnostics' Stock Reaches 52-Week High, Outperforms Sector and Sensex

Aspira Pathlab & Diagnostics Hits 52-Week High, Outperforms Sector Despite Recent Volatility

Bosch to cut over 7,000 jobs as it lowers growth forecast for 2024: What we know | Company Business News

Aspira Pathlab & Diagnostics Ltd's Stock Reaches 52-Week High, Outperforms Sector

Aspira Pathlab & Diagnostics' Stock Surges, Outperforms Sector and Sensex in Strong 1-Year Performance

Aspira Pathlab & Diagnostics Surges to 52-Week High, Outperforming Sector and Sensex

Aspira Pathlab & Diagnostics' Stock Surges to 52-Week High, Outperforming Sector.

Noel Tata will not become Chairman of Tata Sons due to THIS rule | Company Business News

Aspira Pathlab & Diagnostics Stock Surges to 52-Week High, But Receives Strong Sell Rating from MarketsMOJO

HDFC Bank share are down by -0.26%, Nifty down by -0.96% | Company Business News

Aspira Pathlab Standalone June 2024 Net Sales at Rs 4.64 crore, up 78.1% Y-o-Y

Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.02 crore in the June 2024 quarter

Barometers edge higher in early trade; breadth negative

Q1 results today: IRCTC, Hindalco, Hero Motocorp, Nykaa among 668 companies to post earnings on August 13 | Company Business News

Q1 Results, Aug. 13: IRCTC, Hero MotoCorp, SJVN, Hindalco To Declare Earnings Today

Q1 results today: IRCTC, Hindalco, Hero Motocorp, Nykaa among 668 companies to post earnings on August 13

Post global outage, CrowdStrike's compensation of $10 Uber Eats voucher draws criticism | Company Business News

Q1FY25: Adani Green Energy, Nestle India, Ashok Leyland among 76 companies to report results on July 25 | Company Business News

Shares below Rs 100: Only buyers were seen in these stocks on June 26

Q4 Results Today: IRCTC, Aditya Birla Fashion, GIC Among 440+ Companies To Report Earnings

Shares below Rs 100: Only buyers were seen in these stocks on June 11

Aspira Pathlab Standalone March 2024 Net Sales at Rs 3.82 crore, up 12.04% Y-o-Y

Aspira Pathlab & Diagnostics Share Price

Medinova Diagnostic Services Share Price

Shares below Rs 100: Only buyers were seen in these stocks on January 20

Closing Bell: Nifty at 22,100, Sensex gains 760 pts; IT, oil & gas shine

Top Performing Penny Stocks of August 2023

Top Gainers : 'या' आठवड्यात 5 शेअर्सने केलं मालामाल; 74 टक्क्यांपर्यत दिला परतावा; तुमच्या पोर्टफोलिओमध्ये आहेत का?

Only Buyers BSE: BSE Buyers, BSE Only Buyers Today, Upper & Lower Circuit Stocks in BSE

Vinod Bhanushali: Net worth, Biography, age, family, wife, daughter, movies

In pics | Stocks in the news: TCS, Infosys, ACC, Morphen Labs, Tata Elxsi, Infibeam Avenues, Excel...

India's first fully automated lab brought to life by Siemens Healthineers

India’s first fully automated lab brought to life by Siemens Healthineers